Leica Biosystems

ADVANCING CANCER DIAGNOSTICS, IMPROVING LIVES

Dr. Ewa Douroux is a life-science executive with global experience in world-class organisations focusing on medical device, diagnostics, fundamental and clinical research.

Awarded a GOVEA for Victorian Women in International Business in 2018, we spoke to Ewa about her journey as a female business leader with Leica Biosystems.

"As I get to manage more women, I observe that women tend to have a higher inner critic and a more powerful one. I think that initiatives like Global Victoria GOVEA Awards are really helping to move the needle.” Ewa Douroux

Leica Biosystems is a global leader in workflow solutions and automation. As the only company to own the workflow from biopsy to diagnosis, Leica Biosystems are uniquely positioned to break down the barriers between each of these steps.

Their mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of its corporate culture. Their easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. In line with their Mission, Leica Biosystems have established the following challenges for themselves:

Enable patients to get their diagnosis within 24 hours from biopsy. This is a goal they are striving towards, a goal that will guide the company's future strategies. This vision aims to decrease the time it takes from biopsy to patient diagnosis, to a 24 hour period. With a presence in every step of the workflow, no other company is positioned to streamline all these steps so that the whole process takes less than 24 hours.